Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Bioengineered Protein Drugs Market 2018, Forecast to 2023
Scope of the Report:
This report focuses on the Bioengineered Protein Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Bioengineered proteins are designed as the fundamental participants in all biological processes, represent as powerful therapeutic agents and include a broad range of products such as growth factors, hormones, vaccines, monoclonal antibodies, cytokines and few others. These special drugs are gaining attention across pharmaceutical industries due to their specificity, safety, bioreactivity and success rate in treating life-threatening diseases and injuries.
The worldwide market for Bioengineered Protein Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Chapter 1, to describe Bioengineered Protein Drugs Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Bioengineered Protein Drugs, with sales, revenue, and price of Bioengineered Protein Drugs, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Bioengineered Protein Drugs, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Bioengineered Protein Drugs market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Bioengineered Protein Drugs sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
This report focuses on the Bioengineered Protein Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Bioengineered proteins are designed as the fundamental participants in all biological processes, represent as powerful therapeutic agents and include a broad range of products such as growth factors, hormones, vaccines, monoclonal antibodies, cytokines and few others. These special drugs are gaining attention across pharmaceutical industries due to their specificity, safety, bioreactivity and success rate in treating life-threatening diseases and injuries.
The worldwide market for Bioengineered Protein Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
- Abbot
- Amgen
- Baxter
- Bayer
- Eli Lilly
- GlaxoSmithKline
- Fresenius Kabi
- Hoffman-la-Roche
- Johnson & Johnson
- Merck
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
- Recombinant protein drugs
- Peptide hormones
- Vaccines
- Therapeutic enzymes
- Monoclonal antibodies
- Cytokines
- Replacement proteins
- Peptide antibiotics
- Blood products
- Fractionation
- Bioreactors and microbial cell fermentation
- Genetic engineering
- Genetically modified organisms
- Pharming
- Bioengineered protein drugs produced by transgenic microorganisms, plants and animals
- Cell culture
- Others
Chapter 1, to describe Bioengineered Protein Drugs Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Bioengineered Protein Drugs, with sales, revenue, and price of Bioengineered Protein Drugs, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Bioengineered Protein Drugs, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Bioengineered Protein Drugs market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Bioengineered Protein Drugs sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
1 MARKET OVERVIEW
1.1 Bioengineered Protein Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Recombinant protein drugs
1.2.2 Peptide hormones
1.2.3 Vaccines
1.2.4 Therapeutic enzymes
1.2.5 Monoclonal antibodies
1.2.6 Cytokines
1.2.7 Replacement proteins
1.2.8 Peptide antibiotics
1.2.9 Blood products
1.3 Market Analysis by Applications
1.3.1 Fractionation
1.3.2 Bioreactors and microbial cell fermentation
1.3.3 Genetic engineering
1.3.4 Genetically modified organisms
1.3.5 Pharming
1.3.6 Bioengineered protein drugs produced by transgenic microorganisms, plants and animals
1.3.7 Cell culture
1.3.8 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 MANUFACTURERS PROFILES
2.1 Abbot
2.1.1 Business Overview
2.1.1.1 Abbot Description
2.1.1.2 Abbot Headquarter, Main Business and Finance Overview
2.1.2 Abbot Bioengineered Protein Drugs Product Introduction
2.1.2.1 Bioengineered Protein Drugs Production Bases, Sales Regions and Major Competitors
2.1.2.2 Bioengineered Protein Drugs Product Information
2.1.3 Abbot Bioengineered Protein Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.1 Abbot Bioengineered Protein Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.2 Global Abbot Bioengineered Protein Drugs Market Share in 2017
2.2 Amgen
2.2.1 Business Overview
2.2.1.1 Amgen Description
2.2.1.2 Amgen Headquarter, Main Business and Finance Overview
2.2.2 Amgen Bioengineered Protein Drugs Product Introduction
2.2.2.1 Bioengineered Protein Drugs Production Bases, Sales Regions and Major Competitors
2.2.2.2 Bioengineered Protein Drugs Product Information
2.2.3 Amgen Bioengineered Protein Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.1 Amgen Bioengineered Protein Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.2 Global Amgen Bioengineered Protein Drugs Market Share in 2017
2.3 Baxter
2.3.1 Business Overview
2.3.1.1 Baxter Description
2.3.1.2 Baxter Headquarter, Main Business and Finance Overview
2.3.2 Baxter Bioengineered Protein Drugs Product Introduction
2.3.2.1 Bioengineered Protein Drugs Production Bases, Sales Regions and Major Competitors
2.3.2.2 Bioengineered Protein Drugs Product Information
2.3.3 Baxter Bioengineered Protein Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.1 Baxter Bioengineered Protein Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.2 Global Baxter Bioengineered Protein Drugs Market Share in 2017
2.4 Bayer
2.4.1 Business Overview
2.4.1.1 Bayer Description
2.4.1.2 Bayer Headquarter, Main Business and Finance Overview
2.4.2 Bayer Bioengineered Protein Drugs Product Introduction
2.4.2.1 Bioengineered Protein Drugs Production Bases, Sales Regions and Major Competitors
2.4.2.2 Bioengineered Protein Drugs Product Information
2.4.3 Bayer Bioengineered Protein Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.1 Bayer Bioengineered Protein Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.2 Global Bayer Bioengineered Protein Drugs Market Share in 2017
2.5 Eli Lilly
2.5.1 Business Overview
2.5.1.1 Eli Lilly Description
2.5.1.2 Eli Lilly Headquarter, Main Business and Finance Overview
2.5.2 Eli Lilly Bioengineered Protein Drugs Product Introduction
2.5.2.1 Bioengineered Protein Drugs Production Bases, Sales Regions and Major Competitors
2.5.2.2 Bioengineered Protein Drugs Product Information
2.5.3 Eli Lilly Bioengineered Protein Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.1 Eli Lilly Bioengineered Protein Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.2 Global Eli Lilly Bioengineered Protein Drugs Market Share in 2017
2.6 GlaxoSmithKline
2.6.1 Business Overview
2.6.1.1 GlaxoSmithKline Description
2.6.1.2 GlaxoSmithKline Headquarter, Main Business and Finance Overview
2.6.2 GlaxoSmithKline Bioengineered Protein Drugs Product Introduction
2.6.2.1 Bioengineered Protein Drugs Production Bases, Sales Regions and Major Competitors
2.6.2.2 Bioengineered Protein Drugs Product Information
2.6.3 GlaxoSmithKline Bioengineered Protein Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.1 GlaxoSmithKline Bioengineered Protein Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.2 Global GlaxoSmithKline Bioengineered Protein Drugs Market Share in 2017
2.7 Fresenius Kabi
2.7.1 Business Overview
2.7.1.1 Fresenius Kabi Description
2.7.1.2 Fresenius Kabi Headquarter, Main Business and Finance Overview
2.7.2 Fresenius Kabi Bioengineered Protein Drugs Product Introduction
2.7.2.1 Bioengineered Protein Drugs Production Bases, Sales Regions and Major Competitors
2.7.2.2 Bioengineered Protein Drugs Product Information
2.7.3 Fresenius Kabi Bioengineered Protein Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.1 Fresenius Kabi Bioengineered Protein Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.2 Global Fresenius Kabi Bioengineered Protein Drugs Market Share in 2017
2.8 Hoffman-la-Roche
2.8.1 Business Overview
2.8.1.1 Hoffman-la-Roche Description
2.8.1.2 Hoffman-la-Roche Headquarter, Main Business and Finance Overview
2.8.2 Hoffman-la-Roche Bioengineered Protein Drugs Product Introduction
2.8.2.1 Bioengineered Protein Drugs Production Bases, Sales Regions and Major Competitors
2.8.2.2 Bioengineered Protein Drugs Product Information
2.8.3 Hoffman-la-Roche Bioengineered Protein Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.1 Hoffman-la-Roche Bioengineered Protein Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.2 Global Hoffman-la-Roche Bioengineered Protein Drugs Market Share in 2017
2.9 Johnson & Johnson
2.9.1 Business Overview
2.9.1.1 Johnson & Johnson Description
2.9.1.2 Johnson & Johnson Headquarter, Main Business and Finance Overview
2.9.2 Johnson & Johnson Bioengineered Protein Drugs Product Introduction
2.9.2.1 Bioengineered Protein Drugs Production Bases, Sales Regions and Major Competitors
2.9.2.2 Bioengineered Protein Drugs Product Information
2.9.3 Johnson & Johnson Bioengineered Protein Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.3.1 Johnson & Johnson Bioengineered Protein Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.3.2 Global Johnson & Johnson Bioengineered Protein Drugs Market Share in 2017
2.10 Merck
2.10.1 Business Overview
2.10.1.1 Merck Description
2.10.1.2 Merck Headquarter, Main Business and Finance Overview
2.10.2 Merck Bioengineered Protein Drugs Product Introduction
2.10.2.1 Bioengineered Protein Drugs Production Bases, Sales Regions and Major Competitors
2.10.2.2 Bioengineered Protein Drugs Product Information
2.10.3 Merck Bioengineered Protein Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.3.1 Merck Bioengineered Protein Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.3.2 Global Merck Bioengineered Protein Drugs Market Share in 2017
3 GLOBAL BIOENGINEERED PROTEIN DRUGS MARKET COMPETITION, BY MANUFACTURER
3.1 Global Bioengineered Protein Drugs Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Bioengineered Protein Drugs Revenue and Market Share by Manufacturer (2016-2017)
3.3 Global Bioengineered Protein Drugs Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Bioengineered Protein Drugs Manufacturer Market Share in 2017
3.4.2 Top 5 Bioengineered Protein Drugs Manufacturer Market Share in 2017
3.5 Market Competition Trend
4 GLOBAL BIOENGINEERED PROTEIN DRUGS MARKET ANALYSIS BY REGIONS
4.1 Global Bioengineered Protein Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Bioengineered Protein Drugs Sales by Regions (2013-2018)
4.1.2 Global Bioengineered Protein Drugs Revenue by Regions (2013-2018)
4.2 North America Bioengineered Protein Drugs Sales, Revenue and Growth Rate (2013-2018)
4.3 Europe Bioengineered Protein Drugs Sales, Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Bioengineered Protein Drugs Sales, Revenue and Growth Rate (2013-2018)
4.5 South America Bioengineered Protein Drugs Sales, Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Bioengineered Protein Drugs Sales, Revenue and Growth Rate (2013-2018)
5 NORTH AMERICA BIOENGINEERED PROTEIN DRUGS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
5.1 North America Bioengineered Protein Drugs Sales, Revenue and Market Share by Countries
5.1.1 North America Bioengineered Protein Drugs Sales by Countries (2013-2018)
5.1.2 North America Bioengineered Protein Drugs Revenue by Countries (2013-2018)
5.1.3 United States Bioengineered Protein Drugs Sales and Growth Rate (2013-2018)
5.1.4 Canada Bioengineered Protein Drugs Sales and Growth Rate (2013-2018)
5.1.5 Mexico Bioengineered Protein Drugs Sales and Growth Rate (2013-2018)
5.2 North America Bioengineered Protein Drugs Sales and Revenue (Value) by Manufacturers (2016-2017)
5.2.1 North America Bioengineered Protein Drugs Sales by Manufacturers (2016-2017)
5.2.2 North America Bioengineered Protein Drugs Revenue by Manufacturers (2016-2017)
5.3 North America Bioengineered Protein Drugs Sales, Revenue and Market Share by Type (2013-2018)
5.3.1 North America Bioengineered Protein Drugs Sales and Sales Share by Type (2013-2018)
5.3.2 North America Bioengineered Protein Drugs Revenue and Revenue Share by Type (2013-2018)
5.4 North America Bioengineered Protein Drugs Sales, Revenue and Market Share by Application (2013-2018)
5.4.1 North America Bioengineered Protein Drugs Sales and Sales Share by Application (2013-2018)
5.4.2 North America Bioengineered Protein Drugs Revenue and Revenue Share by Application (2013-2018)
6 EUROPE BIOENGINEERED PROTEIN DRUGS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
6.1 Europe Bioengineered Protein Drugs Sales, Revenue and Market Share by Countries
6.1.1 Europe Bioengineered Protein Drugs Sales by Countries (2013-2018)
6.1.2 Europe Bioengineered Protein Drugs Revenue by Countries (2013-2018)
6.1.3 Germany Bioengineered Protein Drugs Sales and Growth Rate (2013-2018)
6.1.4 UK Bioengineered Protein Drugs Sales and Growth Rate (2013-2018)
6.1.5 France Bioengineered Protein Drugs Sales and Growth Rate (2013-2018)
6.1.6 Russia Bioengineered Protein Drugs Sales and Growth Rate (2013-2018)
6.1.7 Italy Bioengineered Protein Drugs Sales and Growth Rate (2013-2018)
6.2 Europe Bioengineered Protein Drugs Sales and Revenue (Value) by Manufacturers (2016-2017)
6.2.1 Europe Bioengineered Protein Drugs Sales by Manufacturers (2016-2017)
6.2.2 Europe Bioengineered Protein Drugs Revenue by Manufacturers (2016-2017)
6.3 Europe Bioengineered Protein Drugs Sales, Revenue and Market Share by Type (2013-2018)
6.3.1 Europe Bioengineered Protein Drugs Sales and Sales Share by Type (2013-2018)
6.3.2 Europe Bioengineered Protein Drugs Revenue and Revenue Share by Type (2013-2018)
6.4 Europe Bioengineered Protein Drugs Sales, Revenue and Market Share by Application (2013-2018)
6.4.1 Europe Bioengineered Protein Drugs Sales and Sales Share by Application (2013-2018)
6.4.2 Europe Bioengineered Protein Drugs Revenue and Revenue Share by Application (2013-2018)
7 ASIA-PACIFIC BIOENGINEERED PROTEIN DRUGS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
7.1 Asia-Pacific Bioengineered Protein Drugs Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Bioengineered Protein Drugs Sales by Countries (2013-2018)
7.1.2 Asia-Pacific Bioengineered Protein Drugs Revenue by Countries (2013-2018)
7.1.3 China Bioengineered Protein Drugs Sales and Growth Rate (2013-2018)
7.1.4 Japan Bioengineered Protein Drugs Sales and Growth Rate (2013-2018)
7.1.5 Korea Bioengineered Protein Drugs Sales and Growth Rate (2013-2018)
7.1.6 India Bioengineered Protein Drugs Sales and Growth Rate (2013-2018)
7.1.7 Southeast Asia Bioengineered Protein Drugs Sales and Growth Rate (2013-2018)
7.2 Asia-Pacific Bioengineered Protein Drugs Sales and Revenue (Value) by Manufacturers (2016-2017)
7.2.1 Asia-Pacific Bioengineered Protein Drugs Sales by Manufacturers (2016-2017)
7.2.2 Asia-Pacific Bioengineered Protein Drugs Revenue by Manufacturers (2016-2017)
7.3 Asia-Pacific Bioengineered Protein Drugs Sales, Revenue and Market Share by Type (2013-2018)
7.3.1 Asia-Pacific Bioengineered Protein Drugs Sales and Sales Share by Type (2013-2018)
7.3.2 Asia-Pacific Bioengineered Protein Drugs Revenue and Revenue Share by Type (2013-2018)
7.4 Asia-Pacific Bioengineered Protein Drugs Sales, Revenue and Market Share by Application (2013-2018)
7.4.1 Asia-Pacific Bioengineered Protein Drugs Sales and Sales Share by Application (2013-2018)
7.4.2 Asia-Pacific Bioengineered Protein Drugs Revenue and Revenue Share by Application (2013-2018)
8 SOUTH AMERICA BIOENGINEERED PROTEIN DRUGS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
8.1 South America Bioengineered Protein Drugs Sales, Revenue and Market Share by Countries
8.1.1 South America Bioengineered Protein Drugs Sales by Countries (2013-2018)
8.1.2 South America Bioengineered Protein Drugs Revenue by Countries (2013-2018)
8.1.3 Brazil Bioengineered Protein Drugs Sales and Growth Rate (2013-2018)
8.1.4 Argentina Bioengineered Protein Drugs Sales and Growth Rate (2013-2018)
8.1.5 Colombia Bioengineered Protein Drugs Sales and Growth Rate (2013-2018)
8.2 South America Bioengineered Protein Drugs Sales and Revenue (Value) by Manufacturers (2016-2017)
8.2.1 South America Bioengineered Protein Drugs Sales by Manufacturers (2016-2017)
8.2.2 South America Bioengineered Protein Drugs Revenue by Manufacturers (2016-2017)
8.3 South America Bioengineered Protein Drugs Sales, Revenue and Market Share by Type (2013-2018)
8.3.1 South America Bioengineered Protein Drugs Sales and Sales Share by Type (2013-2018)
8.3.2 South America Bioengineered Protein Drugs Revenue and Revenue Share by Type (2013-2018)
8.4 South America Bioengineered Protein Drugs Sales, Revenue and Market Share by Application (2013-2018)
8.4.1 South America Bioengineered Protein Drugs Sales and Sales Share by Application (2013-2018)
8.4.2 South America Bioengineered Protein Drugs Revenue and Revenue Share by Application (2013-2018)
9 MIDDLE EAST AND AFRICA BIOENGINEERED PROTEIN DRUGS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
9.1 Middle East and Africa Bioengineered Protein Drugs Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Bioengineered Protein Drugs Sales by Countries (2013-2018)
9.1.2 Middle East and Africa Bioengineered Protein Drugs Revenue by Countries (2013-2018)
9.1.3 Saudi Arabia Bioengineered Protein Drugs Sales and Growth Rate (2013-2018)
9.1.4 UAE Bioengineered Protein Drugs Sales and Growth Rate (2013-2018)
9.1.5 Egypt Bioengineered Protein Drugs Sales and Growth Rate (2013-2018)
9.1.6 Nigeria Bioengineered Protein Drugs Sales and Growth Rate (2013-2018)
9.1.7 South Africa Bioengineered Protein Drugs Sales and Growth Rate (2013-2018)
9.2 Middle East and Africa Bioengineered Protein Drugs Sales and Revenue (Value) by Manufacturers (2016-2017)
9.2.1 Middle East and Africa Bioengineered Protein Drugs Sales by Manufacturers (2016-2017)
9.2.2 Middle East and Africa Bioengineered Protein Drugs Revenue by Manufacturers (2016-2017)
9.3 Middle East and Africa Bioengineered Protein Drugs Sales, Revenue and Market Share by Type (2013-2018)
9.3.1 Middle East and Africa Bioengineered Protein Drugs Sales and Sales Share by Type (2013-2018)
9.3.1 Middle East and Africa Bioengineered Protein Drugs Revenue and Revenue Share by Type (2013-2018)
9.4 Middle East and Africa Bioengineered Protein Drugs Sales, Revenue and Market Share by Application (2013-2018)
9.4.1 Middle East and Africa Bioengineered Protein Drugs Sales and Sales Share by Application (2013-2018)
9.4.2 Middle East and Africa Bioengineered Protein Drugs Revenue and Revenue Share by Application (2013-2018)
10 GLOBAL BIOENGINEERED PROTEIN DRUGS MARKET SEGMENT BY TYPE
10.1 Global Bioengineered Protein Drugs Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Bioengineered Protein Drugs Sales and Market Share by Type (2013-2018)
10.1.2 Global Bioengineered Protein Drugs Revenue and Market Share by Type (2013-2018)
10.2 Recombinant protein drugs Sales Growth and Price
10.2.1 Global Recombinant protein drugs Sales Growth (2013-2018)
10.2.2 Global Recombinant protein drugs Price (2013-2018)
10.3 Peptide hormones Sales Growth and Price
10.3.1 Global Peptide hormones Sales Growth (2013-2018)
10.3.2 Global Peptide hormones Price (2013-2018)
10.4 Vaccines Sales Growth and Price
10.4.1 Global Vaccines Sales Growth (2013-2018)
10.4.2 Global Vaccines Price (2013-2018)
10.5 Therapeutic enzymes Sales Growth and Price
10.5.1 Global Therapeutic enzymes Sales Growth (2013-2018)
10.5.2 Global Therapeutic enzymes Price (2013-2018)
10.6 Monoclonal antibodies Sales Growth and Price
10.6.1 Global Monoclonal antibodies Sales Growth (2013-2018)
10.6.2 Global Monoclonal antibodies Price (2013-2018)
10.7 Cytokines Sales Growth and Price
10.7.1 Global Cytokines Sales Growth (2013-2018)
10.7.2 Global Cytokines Price (2013-2018)
10.8 Replacement proteins Sales Growth and Price
10.8.1 Global Replacement proteins Sales Growth (2013-2018)
10.8.2 Global Replacement proteins Price (2013-2018)
10.9 Peptide antibiotics Sales Growth and Price
10.9.1 Global Peptide antibiotics Sales Growth (2013-2018)
10.9.2 Global Peptide antibiotics Price (2013-2018)
10.10 Blood products Sales Growth and Price
10.10.1 Global Blood products Sales Growth (2013-2018)
10.10.2 Global Blood products Price (2013-2018)
11 GLOBAL BIOENGINEERED PROTEIN DRUGS MARKET SEGMENT BY APPLICATION
11.1 Global Bioengineered Protein Drugs Sales Market Share by Application (2013-2018)
11.2 Fractionation Sales Growth (2013-2018)
11.3 Bioreactors and microbial cell fermentation Sales Growth (2013-2018)
11.4 Genetic engineering Sales Growth (2013-2018)
11.5 Genetically modified organisms Sales Growth (2013-2018)
11.6 Pharming Sales Growth (2013-2018)
11.7 Bioengineered protein drugs produced by transgenic microorganisms, plants and animals Sales Growth (2013-2018)
11.8 Cell culture Sales Growth (2013-2018)
11.9 Others Sales Growth (2013-2018)
12 BIOENGINEERED PROTEIN DRUGS MARKET FORECAST (2018-2023)
12.1 Global Bioengineered Protein Drugs Sales, Revenue and Growth Rate (2018-2023)
12.2 Bioengineered Protein Drugs Market Forecast by Regions (2018-2023)
12.2.1 North America Bioengineered Protein Drugs Market Forecast (2018-2023)
12.2.2 Europe Bioengineered Protein Drugs Market Forecast (2018-2023)
12.2.3 Asia-Pacific Bioengineered Protein Drugs Market Forecast (2018-2023)
12.2.4 South America Bioengineered Protein Drugs Market Forecast (2018-2023)
12.2.5 Middle East and Africa Bioengineered Protein Drugs Market Forecast (2018-2023)
12.3 Bioengineered Protein Drugs Market Forecast by Type (2018-2023)
12.3.1 Global Bioengineered Protein Drugs Sales Forecast by Type (2018-2023)
12.3.2 Global Bioengineered Protein Drugs Market Share Forecast by Type (2018-2023)
12.4 Bioengineered Protein Drugs Market Forecast by Application (2018-2023)
12.4.1 Global Bioengineered Protein Drugs Sales Forecast by Application (2018-2023)
12.4.2 Global Bioengineered Protein Drugs Market Share Forecast by Application (2018-2023)
13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 RESEARCH FINDINGS AND CONCLUSION
15 APPENDIX
15.1 Methodology
15.2 Data Source
1.1 Bioengineered Protein Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Recombinant protein drugs
1.2.2 Peptide hormones
1.2.3 Vaccines
1.2.4 Therapeutic enzymes
1.2.5 Monoclonal antibodies
1.2.6 Cytokines
1.2.7 Replacement proteins
1.2.8 Peptide antibiotics
1.2.9 Blood products
1.3 Market Analysis by Applications
1.3.1 Fractionation
1.3.2 Bioreactors and microbial cell fermentation
1.3.3 Genetic engineering
1.3.4 Genetically modified organisms
1.3.5 Pharming
1.3.6 Bioengineered protein drugs produced by transgenic microorganisms, plants and animals
1.3.7 Cell culture
1.3.8 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 MANUFACTURERS PROFILES
2.1 Abbot
2.1.1 Business Overview
2.1.1.1 Abbot Description
2.1.1.2 Abbot Headquarter, Main Business and Finance Overview
2.1.2 Abbot Bioengineered Protein Drugs Product Introduction
2.1.2.1 Bioengineered Protein Drugs Production Bases, Sales Regions and Major Competitors
2.1.2.2 Bioengineered Protein Drugs Product Information
2.1.3 Abbot Bioengineered Protein Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.1 Abbot Bioengineered Protein Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.2 Global Abbot Bioengineered Protein Drugs Market Share in 2017
2.2 Amgen
2.2.1 Business Overview
2.2.1.1 Amgen Description
2.2.1.2 Amgen Headquarter, Main Business and Finance Overview
2.2.2 Amgen Bioengineered Protein Drugs Product Introduction
2.2.2.1 Bioengineered Protein Drugs Production Bases, Sales Regions and Major Competitors
2.2.2.2 Bioengineered Protein Drugs Product Information
2.2.3 Amgen Bioengineered Protein Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.1 Amgen Bioengineered Protein Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.2 Global Amgen Bioengineered Protein Drugs Market Share in 2017
2.3 Baxter
2.3.1 Business Overview
2.3.1.1 Baxter Description
2.3.1.2 Baxter Headquarter, Main Business and Finance Overview
2.3.2 Baxter Bioengineered Protein Drugs Product Introduction
2.3.2.1 Bioengineered Protein Drugs Production Bases, Sales Regions and Major Competitors
2.3.2.2 Bioengineered Protein Drugs Product Information
2.3.3 Baxter Bioengineered Protein Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.1 Baxter Bioengineered Protein Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.2 Global Baxter Bioengineered Protein Drugs Market Share in 2017
2.4 Bayer
2.4.1 Business Overview
2.4.1.1 Bayer Description
2.4.1.2 Bayer Headquarter, Main Business and Finance Overview
2.4.2 Bayer Bioengineered Protein Drugs Product Introduction
2.4.2.1 Bioengineered Protein Drugs Production Bases, Sales Regions and Major Competitors
2.4.2.2 Bioengineered Protein Drugs Product Information
2.4.3 Bayer Bioengineered Protein Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.1 Bayer Bioengineered Protein Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.2 Global Bayer Bioengineered Protein Drugs Market Share in 2017
2.5 Eli Lilly
2.5.1 Business Overview
2.5.1.1 Eli Lilly Description
2.5.1.2 Eli Lilly Headquarter, Main Business and Finance Overview
2.5.2 Eli Lilly Bioengineered Protein Drugs Product Introduction
2.5.2.1 Bioengineered Protein Drugs Production Bases, Sales Regions and Major Competitors
2.5.2.2 Bioengineered Protein Drugs Product Information
2.5.3 Eli Lilly Bioengineered Protein Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.1 Eli Lilly Bioengineered Protein Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.2 Global Eli Lilly Bioengineered Protein Drugs Market Share in 2017
2.6 GlaxoSmithKline
2.6.1 Business Overview
2.6.1.1 GlaxoSmithKline Description
2.6.1.2 GlaxoSmithKline Headquarter, Main Business and Finance Overview
2.6.2 GlaxoSmithKline Bioengineered Protein Drugs Product Introduction
2.6.2.1 Bioengineered Protein Drugs Production Bases, Sales Regions and Major Competitors
2.6.2.2 Bioengineered Protein Drugs Product Information
2.6.3 GlaxoSmithKline Bioengineered Protein Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.1 GlaxoSmithKline Bioengineered Protein Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.2 Global GlaxoSmithKline Bioengineered Protein Drugs Market Share in 2017
2.7 Fresenius Kabi
2.7.1 Business Overview
2.7.1.1 Fresenius Kabi Description
2.7.1.2 Fresenius Kabi Headquarter, Main Business and Finance Overview
2.7.2 Fresenius Kabi Bioengineered Protein Drugs Product Introduction
2.7.2.1 Bioengineered Protein Drugs Production Bases, Sales Regions and Major Competitors
2.7.2.2 Bioengineered Protein Drugs Product Information
2.7.3 Fresenius Kabi Bioengineered Protein Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.1 Fresenius Kabi Bioengineered Protein Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.2 Global Fresenius Kabi Bioengineered Protein Drugs Market Share in 2017
2.8 Hoffman-la-Roche
2.8.1 Business Overview
2.8.1.1 Hoffman-la-Roche Description
2.8.1.2 Hoffman-la-Roche Headquarter, Main Business and Finance Overview
2.8.2 Hoffman-la-Roche Bioengineered Protein Drugs Product Introduction
2.8.2.1 Bioengineered Protein Drugs Production Bases, Sales Regions and Major Competitors
2.8.2.2 Bioengineered Protein Drugs Product Information
2.8.3 Hoffman-la-Roche Bioengineered Protein Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.1 Hoffman-la-Roche Bioengineered Protein Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.2 Global Hoffman-la-Roche Bioengineered Protein Drugs Market Share in 2017
2.9 Johnson & Johnson
2.9.1 Business Overview
2.9.1.1 Johnson & Johnson Description
2.9.1.2 Johnson & Johnson Headquarter, Main Business and Finance Overview
2.9.2 Johnson & Johnson Bioengineered Protein Drugs Product Introduction
2.9.2.1 Bioengineered Protein Drugs Production Bases, Sales Regions and Major Competitors
2.9.2.2 Bioengineered Protein Drugs Product Information
2.9.3 Johnson & Johnson Bioengineered Protein Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.3.1 Johnson & Johnson Bioengineered Protein Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.3.2 Global Johnson & Johnson Bioengineered Protein Drugs Market Share in 2017
2.10 Merck
2.10.1 Business Overview
2.10.1.1 Merck Description
2.10.1.2 Merck Headquarter, Main Business and Finance Overview
2.10.2 Merck Bioengineered Protein Drugs Product Introduction
2.10.2.1 Bioengineered Protein Drugs Production Bases, Sales Regions and Major Competitors
2.10.2.2 Bioengineered Protein Drugs Product Information
2.10.3 Merck Bioengineered Protein Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.3.1 Merck Bioengineered Protein Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.3.2 Global Merck Bioengineered Protein Drugs Market Share in 2017
3 GLOBAL BIOENGINEERED PROTEIN DRUGS MARKET COMPETITION, BY MANUFACTURER
3.1 Global Bioengineered Protein Drugs Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Bioengineered Protein Drugs Revenue and Market Share by Manufacturer (2016-2017)
3.3 Global Bioengineered Protein Drugs Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Bioengineered Protein Drugs Manufacturer Market Share in 2017
3.4.2 Top 5 Bioengineered Protein Drugs Manufacturer Market Share in 2017
3.5 Market Competition Trend
4 GLOBAL BIOENGINEERED PROTEIN DRUGS MARKET ANALYSIS BY REGIONS
4.1 Global Bioengineered Protein Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Bioengineered Protein Drugs Sales by Regions (2013-2018)
4.1.2 Global Bioengineered Protein Drugs Revenue by Regions (2013-2018)
4.2 North America Bioengineered Protein Drugs Sales, Revenue and Growth Rate (2013-2018)
4.3 Europe Bioengineered Protein Drugs Sales, Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Bioengineered Protein Drugs Sales, Revenue and Growth Rate (2013-2018)
4.5 South America Bioengineered Protein Drugs Sales, Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Bioengineered Protein Drugs Sales, Revenue and Growth Rate (2013-2018)
5 NORTH AMERICA BIOENGINEERED PROTEIN DRUGS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
5.1 North America Bioengineered Protein Drugs Sales, Revenue and Market Share by Countries
5.1.1 North America Bioengineered Protein Drugs Sales by Countries (2013-2018)
5.1.2 North America Bioengineered Protein Drugs Revenue by Countries (2013-2018)
5.1.3 United States Bioengineered Protein Drugs Sales and Growth Rate (2013-2018)
5.1.4 Canada Bioengineered Protein Drugs Sales and Growth Rate (2013-2018)
5.1.5 Mexico Bioengineered Protein Drugs Sales and Growth Rate (2013-2018)
5.2 North America Bioengineered Protein Drugs Sales and Revenue (Value) by Manufacturers (2016-2017)
5.2.1 North America Bioengineered Protein Drugs Sales by Manufacturers (2016-2017)
5.2.2 North America Bioengineered Protein Drugs Revenue by Manufacturers (2016-2017)
5.3 North America Bioengineered Protein Drugs Sales, Revenue and Market Share by Type (2013-2018)
5.3.1 North America Bioengineered Protein Drugs Sales and Sales Share by Type (2013-2018)
5.3.2 North America Bioengineered Protein Drugs Revenue and Revenue Share by Type (2013-2018)
5.4 North America Bioengineered Protein Drugs Sales, Revenue and Market Share by Application (2013-2018)
5.4.1 North America Bioengineered Protein Drugs Sales and Sales Share by Application (2013-2018)
5.4.2 North America Bioengineered Protein Drugs Revenue and Revenue Share by Application (2013-2018)
6 EUROPE BIOENGINEERED PROTEIN DRUGS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
6.1 Europe Bioengineered Protein Drugs Sales, Revenue and Market Share by Countries
6.1.1 Europe Bioengineered Protein Drugs Sales by Countries (2013-2018)
6.1.2 Europe Bioengineered Protein Drugs Revenue by Countries (2013-2018)
6.1.3 Germany Bioengineered Protein Drugs Sales and Growth Rate (2013-2018)
6.1.4 UK Bioengineered Protein Drugs Sales and Growth Rate (2013-2018)
6.1.5 France Bioengineered Protein Drugs Sales and Growth Rate (2013-2018)
6.1.6 Russia Bioengineered Protein Drugs Sales and Growth Rate (2013-2018)
6.1.7 Italy Bioengineered Protein Drugs Sales and Growth Rate (2013-2018)
6.2 Europe Bioengineered Protein Drugs Sales and Revenue (Value) by Manufacturers (2016-2017)
6.2.1 Europe Bioengineered Protein Drugs Sales by Manufacturers (2016-2017)
6.2.2 Europe Bioengineered Protein Drugs Revenue by Manufacturers (2016-2017)
6.3 Europe Bioengineered Protein Drugs Sales, Revenue and Market Share by Type (2013-2018)
6.3.1 Europe Bioengineered Protein Drugs Sales and Sales Share by Type (2013-2018)
6.3.2 Europe Bioengineered Protein Drugs Revenue and Revenue Share by Type (2013-2018)
6.4 Europe Bioengineered Protein Drugs Sales, Revenue and Market Share by Application (2013-2018)
6.4.1 Europe Bioengineered Protein Drugs Sales and Sales Share by Application (2013-2018)
6.4.2 Europe Bioengineered Protein Drugs Revenue and Revenue Share by Application (2013-2018)
7 ASIA-PACIFIC BIOENGINEERED PROTEIN DRUGS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
7.1 Asia-Pacific Bioengineered Protein Drugs Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Bioengineered Protein Drugs Sales by Countries (2013-2018)
7.1.2 Asia-Pacific Bioengineered Protein Drugs Revenue by Countries (2013-2018)
7.1.3 China Bioengineered Protein Drugs Sales and Growth Rate (2013-2018)
7.1.4 Japan Bioengineered Protein Drugs Sales and Growth Rate (2013-2018)
7.1.5 Korea Bioengineered Protein Drugs Sales and Growth Rate (2013-2018)
7.1.6 India Bioengineered Protein Drugs Sales and Growth Rate (2013-2018)
7.1.7 Southeast Asia Bioengineered Protein Drugs Sales and Growth Rate (2013-2018)
7.2 Asia-Pacific Bioengineered Protein Drugs Sales and Revenue (Value) by Manufacturers (2016-2017)
7.2.1 Asia-Pacific Bioengineered Protein Drugs Sales by Manufacturers (2016-2017)
7.2.2 Asia-Pacific Bioengineered Protein Drugs Revenue by Manufacturers (2016-2017)
7.3 Asia-Pacific Bioengineered Protein Drugs Sales, Revenue and Market Share by Type (2013-2018)
7.3.1 Asia-Pacific Bioengineered Protein Drugs Sales and Sales Share by Type (2013-2018)
7.3.2 Asia-Pacific Bioengineered Protein Drugs Revenue and Revenue Share by Type (2013-2018)
7.4 Asia-Pacific Bioengineered Protein Drugs Sales, Revenue and Market Share by Application (2013-2018)
7.4.1 Asia-Pacific Bioengineered Protein Drugs Sales and Sales Share by Application (2013-2018)
7.4.2 Asia-Pacific Bioengineered Protein Drugs Revenue and Revenue Share by Application (2013-2018)
8 SOUTH AMERICA BIOENGINEERED PROTEIN DRUGS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
8.1 South America Bioengineered Protein Drugs Sales, Revenue and Market Share by Countries
8.1.1 South America Bioengineered Protein Drugs Sales by Countries (2013-2018)
8.1.2 South America Bioengineered Protein Drugs Revenue by Countries (2013-2018)
8.1.3 Brazil Bioengineered Protein Drugs Sales and Growth Rate (2013-2018)
8.1.4 Argentina Bioengineered Protein Drugs Sales and Growth Rate (2013-2018)
8.1.5 Colombia Bioengineered Protein Drugs Sales and Growth Rate (2013-2018)
8.2 South America Bioengineered Protein Drugs Sales and Revenue (Value) by Manufacturers (2016-2017)
8.2.1 South America Bioengineered Protein Drugs Sales by Manufacturers (2016-2017)
8.2.2 South America Bioengineered Protein Drugs Revenue by Manufacturers (2016-2017)
8.3 South America Bioengineered Protein Drugs Sales, Revenue and Market Share by Type (2013-2018)
8.3.1 South America Bioengineered Protein Drugs Sales and Sales Share by Type (2013-2018)
8.3.2 South America Bioengineered Protein Drugs Revenue and Revenue Share by Type (2013-2018)
8.4 South America Bioengineered Protein Drugs Sales, Revenue and Market Share by Application (2013-2018)
8.4.1 South America Bioengineered Protein Drugs Sales and Sales Share by Application (2013-2018)
8.4.2 South America Bioengineered Protein Drugs Revenue and Revenue Share by Application (2013-2018)
9 MIDDLE EAST AND AFRICA BIOENGINEERED PROTEIN DRUGS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
9.1 Middle East and Africa Bioengineered Protein Drugs Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Bioengineered Protein Drugs Sales by Countries (2013-2018)
9.1.2 Middle East and Africa Bioengineered Protein Drugs Revenue by Countries (2013-2018)
9.1.3 Saudi Arabia Bioengineered Protein Drugs Sales and Growth Rate (2013-2018)
9.1.4 UAE Bioengineered Protein Drugs Sales and Growth Rate (2013-2018)
9.1.5 Egypt Bioengineered Protein Drugs Sales and Growth Rate (2013-2018)
9.1.6 Nigeria Bioengineered Protein Drugs Sales and Growth Rate (2013-2018)
9.1.7 South Africa Bioengineered Protein Drugs Sales and Growth Rate (2013-2018)
9.2 Middle East and Africa Bioengineered Protein Drugs Sales and Revenue (Value) by Manufacturers (2016-2017)
9.2.1 Middle East and Africa Bioengineered Protein Drugs Sales by Manufacturers (2016-2017)
9.2.2 Middle East and Africa Bioengineered Protein Drugs Revenue by Manufacturers (2016-2017)
9.3 Middle East and Africa Bioengineered Protein Drugs Sales, Revenue and Market Share by Type (2013-2018)
9.3.1 Middle East and Africa Bioengineered Protein Drugs Sales and Sales Share by Type (2013-2018)
9.3.1 Middle East and Africa Bioengineered Protein Drugs Revenue and Revenue Share by Type (2013-2018)
9.4 Middle East and Africa Bioengineered Protein Drugs Sales, Revenue and Market Share by Application (2013-2018)
9.4.1 Middle East and Africa Bioengineered Protein Drugs Sales and Sales Share by Application (2013-2018)
9.4.2 Middle East and Africa Bioengineered Protein Drugs Revenue and Revenue Share by Application (2013-2018)
10 GLOBAL BIOENGINEERED PROTEIN DRUGS MARKET SEGMENT BY TYPE
10.1 Global Bioengineered Protein Drugs Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Bioengineered Protein Drugs Sales and Market Share by Type (2013-2018)
10.1.2 Global Bioengineered Protein Drugs Revenue and Market Share by Type (2013-2018)
10.2 Recombinant protein drugs Sales Growth and Price
10.2.1 Global Recombinant protein drugs Sales Growth (2013-2018)
10.2.2 Global Recombinant protein drugs Price (2013-2018)
10.3 Peptide hormones Sales Growth and Price
10.3.1 Global Peptide hormones Sales Growth (2013-2018)
10.3.2 Global Peptide hormones Price (2013-2018)
10.4 Vaccines Sales Growth and Price
10.4.1 Global Vaccines Sales Growth (2013-2018)
10.4.2 Global Vaccines Price (2013-2018)
10.5 Therapeutic enzymes Sales Growth and Price
10.5.1 Global Therapeutic enzymes Sales Growth (2013-2018)
10.5.2 Global Therapeutic enzymes Price (2013-2018)
10.6 Monoclonal antibodies Sales Growth and Price
10.6.1 Global Monoclonal antibodies Sales Growth (2013-2018)
10.6.2 Global Monoclonal antibodies Price (2013-2018)
10.7 Cytokines Sales Growth and Price
10.7.1 Global Cytokines Sales Growth (2013-2018)
10.7.2 Global Cytokines Price (2013-2018)
10.8 Replacement proteins Sales Growth and Price
10.8.1 Global Replacement proteins Sales Growth (2013-2018)
10.8.2 Global Replacement proteins Price (2013-2018)
10.9 Peptide antibiotics Sales Growth and Price
10.9.1 Global Peptide antibiotics Sales Growth (2013-2018)
10.9.2 Global Peptide antibiotics Price (2013-2018)
10.10 Blood products Sales Growth and Price
10.10.1 Global Blood products Sales Growth (2013-2018)
10.10.2 Global Blood products Price (2013-2018)
11 GLOBAL BIOENGINEERED PROTEIN DRUGS MARKET SEGMENT BY APPLICATION
11.1 Global Bioengineered Protein Drugs Sales Market Share by Application (2013-2018)
11.2 Fractionation Sales Growth (2013-2018)
11.3 Bioreactors and microbial cell fermentation Sales Growth (2013-2018)
11.4 Genetic engineering Sales Growth (2013-2018)
11.5 Genetically modified organisms Sales Growth (2013-2018)
11.6 Pharming Sales Growth (2013-2018)
11.7 Bioengineered protein drugs produced by transgenic microorganisms, plants and animals Sales Growth (2013-2018)
11.8 Cell culture Sales Growth (2013-2018)
11.9 Others Sales Growth (2013-2018)
12 BIOENGINEERED PROTEIN DRUGS MARKET FORECAST (2018-2023)
12.1 Global Bioengineered Protein Drugs Sales, Revenue and Growth Rate (2018-2023)
12.2 Bioengineered Protein Drugs Market Forecast by Regions (2018-2023)
12.2.1 North America Bioengineered Protein Drugs Market Forecast (2018-2023)
12.2.2 Europe Bioengineered Protein Drugs Market Forecast (2018-2023)
12.2.3 Asia-Pacific Bioengineered Protein Drugs Market Forecast (2018-2023)
12.2.4 South America Bioengineered Protein Drugs Market Forecast (2018-2023)
12.2.5 Middle East and Africa Bioengineered Protein Drugs Market Forecast (2018-2023)
12.3 Bioengineered Protein Drugs Market Forecast by Type (2018-2023)
12.3.1 Global Bioengineered Protein Drugs Sales Forecast by Type (2018-2023)
12.3.2 Global Bioengineered Protein Drugs Market Share Forecast by Type (2018-2023)
12.4 Bioengineered Protein Drugs Market Forecast by Application (2018-2023)
12.4.1 Global Bioengineered Protein Drugs Sales Forecast by Application (2018-2023)
12.4.2 Global Bioengineered Protein Drugs Market Share Forecast by Application (2018-2023)
13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 RESEARCH FINDINGS AND CONCLUSION
15 APPENDIX
15.1 Methodology
15.2 Data Source
LIST OF TABLES AND FIGURES
Figure Bioengineered Protein Drugs Picture
Table Product Specifications of Bioengineered Protein Drugs
Figure Global Bioengineered Protein Drugs CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-20
Figure Bioengineered Protein Drugs Picture
Table Product Specifications of Bioengineered Protein Drugs
Figure Global Bioengineered Protein Drugs CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-20
